GPR35 agonist 4 (compound 10) serves as a potent GPR35 agonist, showcasing a pEC50 of 5.86, indicating its high potency towards both human and rat GPR35. Notably, the mutation of arginine at position 3.36 results in the loss of the compound's agonist function on GPR35 (1).